Add on effect of Whole System Ayurveda protocol in suboptimal controlled Primary Hypothyroidism - A randomized controlled trial

IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE
Vivek , Arun Chougale , Himanshu Joshi , Basavaraj R. Tubaki
{"title":"Add on effect of Whole System Ayurveda protocol in suboptimal controlled Primary Hypothyroidism - A randomized controlled trial","authors":"Vivek ,&nbsp;Arun Chougale ,&nbsp;Himanshu Joshi ,&nbsp;Basavaraj R. Tubaki","doi":"10.1016/j.jaim.2024.101052","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Primary hypothyroidism (PH) is a common chronic life style disorder. Whole system <em>Ayurveda protocol</em> on PH <em>(WSAPH)</em> is explored for it's possible complimentary role in the management of suboptimal controlled PH on stable levothyroxine therapy.</div></div><div><h3>Objective</h3><div>To evaluate the efficacy of whole system Ayurveda protocol on Primary hypothyroidism with suboptimal response to stable levothyroxine therapy.</div></div><div><h3>Material and methods</h3><div>Study was a randomized controlled trial. Total 46 known patients of suboptimal response to stable levothyroxine therapy, age group 20–60 years of either sex participated in the study. They were randomly placed in two groups, Group KG received Kanchanara guggulu two tablets of 500 mg each, thrice a day with water and group WSAPH was on whole system Ayurveda protocol for primary hypothyroidism (WSAPH). Interventions were for 60 days. Assessments were done through various parameters like Thyroid profiles (TSH, T3, T4, Free T4), Weight, BMI, Skin fold thickness (SFT), Body fat index (BFI), Waist hip ratio (WHR), Lipid profile, Zulewskis clinical score for hypothyroidism (ZUL), WHO Quality of Life- BREF (WHOQOL-BREF), Clinical Global Improvement scales (CGI). Clinical assessments were done on every 15th day and biochemical were done before and after interventions.</div></div><div><h3>Results</h3><div>Study showed that WSAPH group produced significant outcome improvement compared to KG group in TSH (p = 0.02), weight (p = 0.02), SFT (p = 0.04), BFI (p = 0.01), WHOQOL-BREF (p = 0.004) and ZUL (p = 0.02). Both the group showed improvements in BMI, WHR, BFI, SFT, WHOQOL-BREF, ZUL, CGI scales. Effect size was medium in TSH, weight, BFI, SFT and ZUL.</div></div><div><h3>Conclusion</h3><div><em>WSAPH</em> was effective in management of PH and normalized TSH and ZUL scores in patients with suboptimal response to stable levothyroxine therapy. Further studies are needed.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 1","pages":"Article 101052"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11773014/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda and Integrative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0975947624001670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Primary hypothyroidism (PH) is a common chronic life style disorder. Whole system Ayurveda protocol on PH (WSAPH) is explored for it's possible complimentary role in the management of suboptimal controlled PH on stable levothyroxine therapy.

Objective

To evaluate the efficacy of whole system Ayurveda protocol on Primary hypothyroidism with suboptimal response to stable levothyroxine therapy.

Material and methods

Study was a randomized controlled trial. Total 46 known patients of suboptimal response to stable levothyroxine therapy, age group 20–60 years of either sex participated in the study. They were randomly placed in two groups, Group KG received Kanchanara guggulu two tablets of 500 mg each, thrice a day with water and group WSAPH was on whole system Ayurveda protocol for primary hypothyroidism (WSAPH). Interventions were for 60 days. Assessments were done through various parameters like Thyroid profiles (TSH, T3, T4, Free T4), Weight, BMI, Skin fold thickness (SFT), Body fat index (BFI), Waist hip ratio (WHR), Lipid profile, Zulewskis clinical score for hypothyroidism (ZUL), WHO Quality of Life- BREF (WHOQOL-BREF), Clinical Global Improvement scales (CGI). Clinical assessments were done on every 15th day and biochemical were done before and after interventions.

Results

Study showed that WSAPH group produced significant outcome improvement compared to KG group in TSH (p = 0.02), weight (p = 0.02), SFT (p = 0.04), BFI (p = 0.01), WHOQOL-BREF (p = 0.004) and ZUL (p = 0.02). Both the group showed improvements in BMI, WHR, BFI, SFT, WHOQOL-BREF, ZUL, CGI scales. Effect size was medium in TSH, weight, BFI, SFT and ZUL.

Conclusion

WSAPH was effective in management of PH and normalized TSH and ZUL scores in patients with suboptimal response to stable levothyroxine therapy. Further studies are needed.

Abstract Image

全系统阿育吠陀方案对亚理想控制原发性甲状腺功能减退的影响-一项随机对照试验。
背景:原发性甲状腺功能减退症(PH)是一种常见的慢性生活方式障碍。探讨阿育吠陀PH全系统方案(wwsh)在稳定左甲状腺素治疗控制PH次优的管理中可能发挥的补充作用。目的:评价阿育吠陀全系统治疗原发性甲状腺功能减退症对稳定左甲状腺素治疗反应不佳的疗效。材料与方法:研究为随机对照试验。共有46例已知对稳定左甲状腺素治疗反应不佳的患者,年龄20-60岁,男女不限。随机分为两组,KG组患者给予Kanchanara gugugululu 2片,每片500 mg,每日3次,加水治疗;wwsh组患者采用全系统阿育吠陀治疗原发性甲状腺功能减退(wwsh)。干预期为60天。通过各种参数进行评估,如甲状腺谱(TSH、T3、T4、游离T4)、体重、BMI、皮肤厚度(SFT)、体脂指数(BFI)、腰臀比(WHR)、脂质谱、Zulewskis甲状腺功能减退临床评分(ZUL)、WHO生活质量-BREF (WHOQOL-BREF)、临床总体改善量表(CGI)。每15天进行一次临床评估,干预前后进行生化检查。结果:与KG组比较,wwsh组在TSH (p = 0.02)、体重(p = 0.02)、SFT (p = 0.04)、BFI (p = 0.01)、WHOQOL-BREF (p = 0.004)、ZUL (p = 0.02)方面均有显著改善。两组BMI、WHR、BFI、SFT、WHOQOL-BREF、ZUL、CGI量表均有改善。TSH、体重、BFI、SFT和ZUL的效应量为中等。结论:在对稳定左甲状腺素治疗反应不佳的患者中,wwsh可有效管理PH、TSH和ZUL标准化评分。需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Ayurveda and Integrative Medicine
Journal of Ayurveda and Integrative Medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-
CiteScore
4.70
自引率
12.50%
发文量
136
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信